Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advanced Accelerator Applications SA

Division of Novartis AG
www.adacap.com

Latest From Advanced Accelerator Applications SA

Hudson To Succeed Brandicourt As Sanofi CEO

All change at the top for Sanofi which has poached Novartis pharma chief Paul Hudson to succeed Olivier Brandicourt as CEO.

Leadership Strategy

CHMP Highlights: No For Xyndari, Edaravone MAA Pulled And Good News For Univar’s Cufence

This month’s meeting of the European Medicines Agency’s CHMP appears to have been eventful. One marketing authorization application was rejected, one was pulled, and an earlier negative opinion was upheld. Four MAAs were recommended for approval, including a new treatment from Univar for Wilson’s disease.

Europe Regulation

Novartis' New Oncology CEO Schaffert Has A Potential Blockbuster Launch On Her Hands

In an interview at Novartis' research campus in Cambridge, Mass., Schaffert spoke about the upcoming launch of Piqray for breast cancer, building in radiopharmaceuticals, Kymriah's ongoing manufacturing challenges and more.

Cancer Business Strategies

US FDA Expanded Access Pilot Launching Soon With Staffing Questions Unanswered

New call center is designed to help physicians navigate the expanded access pathway for oncology products, but FDA officials are unsure about how much interest it will generate.

Clinical Trials Cancer
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Molecular Imaging
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Infectious & Viral Diseases
  • Inflammation
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Novartis AG
  • Senior Management
  • Stefano Buono, CEO
    Heinz Mausli, CFO
    Claude Hariton, Head, R&D
    Gerard Ber, COO
  • Contact Info
  • Advanced Accelerator Applications SA
    Phone: 4 50 99 30 70
    20 Rue Diesel
    Saint Genis Pouilly, 01630
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register